Remedium Capital Partners, LLC 13F Portfolio
| Entity | Category | QoQ AUM Change | AUM (13F) | # of Holdings | Performance Rank | Equities Trend |
|---|---|---|---|---|---|---|
RC Remedium Capital Partners, LLC | Institutional Filer | ▲ 187766.13% | $319.8M | 6 |
Current Portfolio Holdings
Showing all 6 reported positions by value
| # | Stock | Company Name | Sector | Shares Held | Market Value | % of Portfolio |
|---|---|---|---|---|---|---|
| 1 | SYRE | Spyre Therapeutics, Inc. | Healthcare | 1.9M | $96.2M | 30.09% |
| 2 | ORKA | Oruka Therapeutics, Inc. | Healthcare | 1.9M | $92.7M | 28.98% |
| 3 | GLTO | Galecto, Inc. | Healthcare | 2.0M | $53.0M | 16.57% |
| 4 | APGE | Apogee Therapeutics, Inc. | Healthcare | 584K | $49.1M | 15.36% |
| 5 | JBIO | Jade Biosciences, Inc. | Healthcare | 1.6M | $22.2M | 6.93% |
| 6 | CBIOXXXX | Crescent Biopharma Inc | — | 361K | $6.6M | 2.08% |
Showing 1 to 6 of 6 holdings